Huge SPY Gains, KEGS News Alert & More

Massive SPY Gains: 

Monday is upon us once again and we’re ready to kick the tires and light the fires on another big trading week. We made out like bandits on Friday, after signaling some SPY calls in our premarket report, one of which registered one of the largest single session gains our ideas have yielded this year.

Both of our quick-strike targets put up positive figures. Specifically, we were looking at the SPY 04/01 $452-453 Calls, and the BABA Weekly $112-116 Calls. and the potential gains from which were as follows:

SPY 04/01 $452-453 Calls
 .07-1.23 (+1657%)
$453: .01-.40 (+3900%)

BABA Weekly $112-116 Calls
 3.36-5.00 (+49%)
$113: 1.41-6.10 (+333%)
$114: 2.03-3.25 (+60%)
$115: 1.51-2.52 (+67%)
$166: .85-3.50 (+312%)

Fresh Options Ideas:
TWTR Weekly $44-45.50 Calls
B 06/17 $40-45 Calls

1812 Brewing Company, Inc. KEGS – News Update:

We’ve also got another major PR update from KEGS this morning which could have significant impact on the stock moving forward, so this is definitely something that requires our immediate attention.

The company is moving to reduce its number of authorized shares by half, with an allusion to even further reductions at a later date. Share reductions can go a long way to increasing the overall health and attractiveness of a stock, KEGS certainly seems committed to that mission.

Watertown, NY, April 04, 2022 (GLOBE NEWSWIRE) — 1812 BREWING COMPANY, INC. (OTC Pink: KEGS) (the “Company”) is pleased to announce that it shall reduce the Company’s authorized shares by 50%.  “It’s hard to imagine a scenario wherein the Company would need to issue 20 billion shares, and to have the Authorized Shares at that level may even be counterproductive to our ongoing efforts to reduce the Company’s overall cost of capital” stated Chairman and CEO Tom Scozzafava.  He continued, “This is a case where perception can create the reality.  If it is perceived that that many shares must be issued to fund your company, then that many shares may just, in fact, be needed.  And that certainly is not our intent.”

The Company’s current Authorized Shares are approximately 20 billion, the move would decrease that to approximately 10 billion.  Finally, Mr. Scozzafava stated, “and if operations continue to progress as they have been, an additional 50% decrease from there is likely.”  The Authorized Share reduction is subject to shareholder and board resolutions and an accepted filing with the State of Florida. (>>View PR)

Extended Watchlist: 

Blue Horseshoe Stocks: Killing it On the Options Front

Killing it On the Options Front 

It seems each time we put out new ideas for potential options trades, tjhat we are met with instant success. Such has been the case for the last several calls as it seems we identify winners much more often than not. Most recently, yesterday morning in our premarket report, we highlighted some possible plays in TGT nand LOW, and they both turned in a winning card on the day.

Here are the trading ranges and total possible single-session profits that were available to anyone who happened to act on our suggestions:

TGT Weekly $98-101 Calls  
$98 Calls – Range: 2.18-5.40 – Max Gain: 128%
$99 Calls – Range: 1.64-4.35  – Max Gain: 166%
$100 Calls – Range: 1.20-3.63 – Max Gain: 203%
*$101 Calls – Produced similar gains, however we were unable to pull up the corresponding data.

Update: We want to roll up and monitor the TGT Weekly $103-104 Calls into the end of the week. 

LOW Weekly $107-110 Calls
$107 Calls – Range: 1.95-3.20 – Max Gain: 64%
$108 Calls – Range: 1.40-2.47 – Max Gain: 76%
$109 Calls – Range: .95-1.94 – Max Gain: 104%
$110 Calls – Range: .60-1.41 – Max Gain: 135%

Fresh Idea:
DKS Weekly $34.50-36 Calls
LB 09/13 $20-21 Calls 

Extended Watchlist:

Blue Horseshoe Stocks: Options 5-Pack

GlaxoSmithKline plc GSK – Final Recap

Wednesday morning, we formulated an idea for the GSK options chain, which we updated our reader on just yesterday. But after a second consecutive solid session, we did observe some new highs in all three of our designated contracts, which were the GSK Weekly $39.50-40.50 Calls.

The updated two-day swing ranges on each of those ideas:

$39.50 Calls – Range: .65-1.40 – Max Gain: 115%
$40 Calls – Range: .15-1.00 – Max Gain: 566%
$40.50 Calls – Range: .10-.60 – Max Gain: 500%

GSK just continues the trend of fantastic options calls we’ve made in 2019 so far. While we don’t have exact figures worked out, it would seem at least 80-90% of the options ideas we’ve formulated have produced multi-bag gain opportunities, and we invite our readers to go through our newsletter feed at and see for yourself!

Fresh Idea:
In the spirit of the great success we’ve had with options, we’re going to finish out the week in a big way with five fresh ideas!

Expedia Group, Inc. EXPE Weekly $134-136 Calls
Coty, Inv. COTY Weekly $8-9 Calls
SPDR S&P 500 ETF (SPY) Weekly $270.50-269 Puts
Sketchers USA Inc. SKX Weekly $30-33 Calls
Tupperware, Inc. TUP 07/19 $25 & $30 Calls

*Please note that our ideas for trading contracts with a weekly expiration on Fridays are intended STRICTLY for advanced level traders with disposable funds with which to work!

3pea International, Inc. TPNL

We also want to briefly recap the solid singkle-session performance of TPNL following its inclusion in yesterday’s morning’s premarket report. The stock produced an intraday run from 5.06 to 7.18, which works out to a gain of 42% and was good for the top gainer spot on the entire NASDAQ yesterday.

Extended Watchlist: